EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Treating Alzheimer’s disease using nanoparticle-mediated drug delivery strategies/systems

Aryan Kia Roghani, Ricardo Isaiah Garcia, Ali Roghani, Aananya Reddy, Sachi Khemka, Ruhananhad P Reddy, Vasanthkumar Pattoor, Michael Jacob, P Hemachandra Reddy, Ujala Sehar

Ageing Research Reviews · 2024-06 · 97 · 102291

DOI: 10.1016/j.arr.2024.102291 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2024-06. Verfasst von Aryan Kia Roghani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA; Frenship High School, Lubbock, TX 79382, USA. …. Hauptthemen laut MEDLINE: Alzheimer Disease, Drug Delivery Systems, Blood-Brain Barrier, Nanoparticles. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 247 Literaturangaben. Gefördert von: NIA NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The administration of promising medications for the treatment of neurodegenerative disorders (NDDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) is significantly hampered by the blood-brain barrier (BBB). Nanotechnology has recently come to light as a viable strategy for overcoming this obstacle and improving drug delivery to the brain. With a focus on current developments and prospects, this review article examines the use of nanoparticles to overcome the BBB constraints to improve drug therapy for AD The potential for several nanoparticle-based approaches, such as those utilizing lipid-based, polymeric, and inorganic nanoparticles, to enhance drug transport across the BBB are highlighted. To shed insight on their involvement in aiding effective drug transport to the brain, methods of nanoparticle-mediated drug delivery, such as surface modifications, functionalization, and particular targeting ligands, are also investigated. The article also discusses the most recent findings on innovative medication formulations encapsulated within nanoparticles and the therapeutic effects they have shown in both preclinical and clinical testing. This sector has difficulties and restrictions, such as the need for increased safety, scalability, and translation to clinical applications. However, the major emphasis of this review aims to provide insight and contribute to the knowledge of how nanotechnology can potentially revolutionize the worldwide treatment of NDDs, particularly AD, to enhance clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDrug Delivery SystemsBlood-Brain BarrierNanoparticlesHumansAnimalsNanoparticle Drug Delivery System

Stichwörter der Autor:innen

Alzheimer's diseaseBlood-brain barrierNanoparticlesPotential developmentsTherapeutic interventions

Substanzen

Nanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA; Frenship High School, Lubbock, TX 79382, USA. Electronic address: tabrizi1008@gmail.com.
  • Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA. Electronic address: isaiah.garcia@ttuhsc.edu.
  • Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA. Electronic address: tabrizi1008@yahoo.com.
  • Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA; Lubbock High School, Lubbock, TX 79401, USA. Electronic address: aanreddy6@gmail.com.
  • Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA. Electronic address: Sachi.Khemka@ttuhsc.edu.
  • Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA; Lubbock High School, Lubbock, TX 79401, USA. Electronic address: ruhananhadreddy@gmail.com.

Förderung

  • NIA NIH HHS
  • National Institutes of Health

Zitieren

APA

Roghani, A. K., Garcia, R. I., Roghani, A., Reddy, A., Khemka, S., Reddy, R. P., Pattoor, V., Jacob, M., Reddy, P. H., & Sehar, U. (2024). Treating Alzheimer’s disease using nanoparticle-mediated drug delivery strategies/systems. Ageing Research Reviews, 97, 102291. https://doi.org/10.1016/j.arr.2024.102291

Vancouver

Roghani AK, Garcia RI, Roghani A, Reddy A, Khemka S, Reddy RP, et al. Treating Alzheimer’s disease using nanoparticle-mediated drug delivery strategies/systems. Ageing Research Reviews. 2024;97:102291. doi:10.1016/j.arr.2024.102291

BibTeX
@article{Roghani2024,
  author = {Roghani, Aryan Kia and Garcia, Ricardo Isaiah and Roghani, Ali and Reddy, Aananya and Khemka, Sachi and Reddy, Ruhananhad P and Pattoor, Vasanthkumar and Jacob, Michael and Reddy, P Hemachandra and Sehar, Ujala},
  title = {Treating Alzheimer’s disease using nanoparticle-mediated drug delivery strategies/systems},
  journal = {Ageing Research Reviews},
  year = {2024},
  volume = {97},
  pages = {102291},
  doi = {10.1016/j.arr.2024.102291}
}
Kostenlos starten →